These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9554780)

  • 1. Coronary embolism following aortic and mitral valve replacement: successful management with abciximab and urokinase.
    Quinn EG; Fergusson DJ
    Cathet Cardiovasc Diagn; 1998 Apr; 43(4):457-9. PubMed ID: 9554780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of a large intracoronary thrombus with urokinase and a chimeric monoclonal platelet aggregation inhibitor].
    Eick B; Haude M; Altmann C; Liu F; Caspari G; Leischik R; Erbel R
    Dtsch Med Wochenschr; 1997 May; 122(22):709-15. PubMed ID: 9213535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of abciximab use in conjunction with intracoronary urokinase in patients requiring angioplasty.
    Rashdan I; Schechter E
    Catheter Cardiovasc Interv; 2000 Jan; 49(1):113-6. PubMed ID: 10627383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty.
    Garbarz E; Farah B; Vuillemenot A; André F; Angioï M; Machecourt J; Bassand JP; Wolf JE; Danchin N; Prendergast B; Iung B; Vahanian A
    Am J Cardiol; 1998 Sep; 82(6):800-3, A9. PubMed ID: 9761094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia.
    Michaels AD; Whisenant B; MacGregor JS
    Clin Cardiol; 1998 Feb; 21(2):134-8. PubMed ID: 9491958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quick resolution with abciximab of giant coronary thrombus].
    Delcán Domínguez JL; García Fernández E; Guerrero Sanz JE
    Rev Esp Cardiol; 2002 May; 55(5):536. PubMed ID: 12015935
    [No Abstract]   [Full Text] [Related]  

  • 7. Instant dissolution of intracoronary thrombus by abciximab.
    Lee CH; Ho KT; Tan HC
    Int J Cardiol; 2005 Sep; 104(1):102-3. PubMed ID: 16137518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful intra-arterial thrombolysis beyond the accepted 6-hour time window in two young patients.
    Coster S; van Dijk LC; Treurniet FE; van Overhagen H; van Woerkom TC
    J Neurol Sci; 2010 Jan; 288(1-2):182-5. PubMed ID: 19863970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined, superselective pharmacological management of large coronary thrombus burden.
    Cortese B; Micheli A; Picchi A; Limbruno U
    J Invasive Cardiol; 2009 Apr; 21(4):168-71. PubMed ID: 19342755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.
    Kwon OK; Lee KJ; Han MH; Oh CW; Han DH; Koh YC
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):447-51. PubMed ID: 11901016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery.
    Rechavia E; Wurzel M
    Circulation; 1998 Sep; 98(12):1249-50. PubMed ID: 9743517
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis.
    Tepe G; Schott U; Erley CM; Albes J; Claussen CD; Duda SH
    AJR Am J Roentgenol; 1999 May; 172(5):1343-6. PubMed ID: 10227513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion.
    Bertrand OF; Meerkin D; de Guise P; Crépeau J; Bourassa MG
    Can J Cardiol; 2000 Jan; 16(1):83-5. PubMed ID: 10653937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive therapies in the cath lab. Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease.
    Chandwaney RH; Stathopoulos T; Sunew J; McPherson D; Davidson CJ
    J Invasive Cardiol; 2001 Sep; 13(9):651-3. PubMed ID: 11533505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of abciximab in the prevention of the acute thrombotic complications of coronary angioplasty].
    Mesquita A; Baptista J; Almeida M; Ferreira J; Machado F; Palos L; Silva A; Seabra-Gomes R
    Rev Port Cardiol; 1997 Dec; 16(12):1031-5. PubMed ID: 9522626
    [No Abstract]   [Full Text] [Related]  

  • 16. Complications associated with combined use of abciximab and an intracoronary thrombolytic agent (urokinase or tissue-type plasminogen activator).
    Yaryura RA; Zaqqa M; Ferguson JJ
    Am J Cardiol; 1998 Aug; 82(4):518-9. PubMed ID: 9723644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty.
    Muhlestein JB; Karagounis LA; Treehan S; Anderson JL
    J Am Coll Cardiol; 1997 Dec; 30(7):1729-34. PubMed ID: 9385900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): trial study design and rationale.
    Sardella G; Sangiorgi GM; Mancone M; Colantonio R; Donahue M; Politi L; Bucciarelli-Ducci C; Carbone I; Francone M; Ligabue G; Fiocchi F; Di Roma A; Benedetti G; Lucisano L; Stio RE; Agati L; Modena MG; Genuini I; Fedele F; Gibson M
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):529-35. PubMed ID: 19918189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.
    Khan MM; Ellis SG; Aguirre FV; Weisman HF; Wildermann NM; Califf RM; Topol EJ; Kleiman NS
    J Am Coll Cardiol; 1998 Jan; 31(1):31-6. PubMed ID: 9426014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
    Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M
    Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.